Pedram Kazemian, MD, MSc, MPH, FRCPC, FACC, FACP

Cardiac Electrophysiologist
Medical Director of Clinical Research


  • Internal Medicine–University of Toronto, Toronto, Canada

Specialty Training

  • Cardiology–University of Alberta, Edmonton, Canada
  • Clinical Cardiac Electrophysiology–Harvard University, Brigham and Women’s Hospital, Boston
  • Clinical Effectiveness (MPH program)–Harvard School of Public Health, Boston
  • Advanced Clinical Cardiac Electrophysiology–Tufts University, Steward St. Elizabeth’s Medical Center, Boston

Board Certified

  • Internal Medicine
  • Cardiovascular Medicine
  • Clinical Cardiac Electrophysiology

Special Interests

  • Atrial Fibrillation
  • Heart Failure
  • Ablations for Ventricular Tachycardia


  • Kazemian P, Jugdutt, BI— Atrial Fibrillation and Heart failure in the Aging Population. In: Jugdutt BI (ed). Aging and Heart Failure: Mechanism & Management. New York, NY: Springer Verlag; 2014 (In Press).
  • Blankstein, R., M. Osborne, Kazemian, P, et al. (2013). Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients with Suspected Cardiac Sarcoidosis. J Am Coll Cardiol (2013).
  • Manlucu J, Brancato S, Lane C, Kazemian P, Michaud GF, Contemporary Approaches to Persistent Atrial Fibrillation. Expert Rev Cardiovasc Ther 10(11): 1421-1435 (2012).
  • Kazemian, P, SM Kazemi-Bajestani et al. The Use of Omega-3 Poly-Unsaturated Fatty Acids in Heart Failure: A Preferential Role in Patients with Diabetes. Cardiovasc Drugs Ther, 26(4):311-20 (2012).
  • Kazemian P, Oudit G, Jugdutt BI, Atrial Fibrillation and Heart Failure in the Elderly. Heart Fail Rev, 17(4-5):597-613 (2012).